Skip to main content

Table 3 Comparison of AEs between sorafenib and RT

From: Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis

  Sorafenib RT
Grade 3/4 toxicity   
Total (n) 19 1
AST/ALT increased 6 0
Anorexia/nausea 4 0
HFSR 3 0
Hepatic Failure 1 0
Ascites 1 0
Hypertension 1 0
Proteinuria 1 0
Sepsis 1 0
Thrombocytopenia 1 0
Anemia 0 0
Leukocytopenia 0 1
Pancreatitis 0 0
Discontinuation, n (%) 15 (54) 1 (4)
  1. Abbreviations: AEs adverse events, AST aspartate aminotransferase, ALT alanine aminotransferase, RT radiotherapy, HFSR hand-foot-skin reaction.